Woodard Jr Joseph Paul 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Apr 26, 2019
Insider Transaction Report
Form 4
Woodard Jr Joseph Paul
SVP Clinical & Medical Affairs
Transactions
- Award
Stock Option (right to buy)
2019-04-25+25,000→ 25,000 totalExercise: $3.01Exp: 2029-04-24→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on April 25, 2020, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.